Cancer trials

Trials closed to recruitment, in follow-up

CamBMT1

Brain metastases occur in 20% to 40% of all patients with cancer, with an incidence 10 times higher than that of primary malignant brain tumours. Patients with brain metastases are an underserved population. Overall, they have a poor prognosis…

COMET20d

COVID-19 targets the body's respiratory system, where infections can be found in the nose, throat and lungs. The effect of COVID-19 infection is very variable, where many people might not know that they have been infected and have recovered from…

INTERIM

Melanoma is the most lethal form of skin cancer: over 13,000 patients are diagnosed in the United Kingdom (UK) annually. Although the majority of patients are diagnosed with primary tumours that can be removed by surgery, around 20% will relapse…

LUCID

Taking as reference tumour-specific somatic genetic alterations identified within individual cancer biopsies from patients, recent advances in genomic and next generation sequencing technologies now provide the opportunity to investigate whether…